Search - tctmd.com

Displaying 321 - 340 of 1357

Sort: Relevancy | Date

News Features

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

Todd Neale

October 17, 2022

News Daily News

Aortic Dissection Risk Rises With Thoracic Aneurysm Size: Large Network Study

Yael L. Maxwell

October 10, 2022

News Conference News HFSA 2022

No Benefit of LAA Ligation During HeartMate 3 Implantation: MOMENTUM 3

Yael L. Maxwell

October 07, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2022

Shelley Wood

October 03, 2022

News Daily News

Another DOAC Fails in the Setting of Mechanical Heart Valves

Todd Neale

September 28, 2022

News Conference News TCT 2022

Pascal TEER Device Performs Well in Patients With Complex Anatomy

Yael L. Maxwell

September 26, 2022

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4

Yael L. Maxwell

September 23, 2022

News Conference News TCT 2022

Valve Fracture for ViV TAVI Linked With Higher Mortality

Michael O'Riordan

September 22, 2022

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Caitlin E. Cox

September 19, 2022

News Conference News TCT 2022

Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning

Shelley Wood

September 19, 2022

News Conference News TCT 2022

Newer FlexNav Delivery System Improves Placement of Portico TAVI Valve

Todd Neale

September 19, 2022

Presentation TCT 2022

TCT 360: The Importance of Leaflet Design in Initiation and Growth of Leaflet Thrombosis in Transcatheter Aortic Valves

Presenter: Ali Azadani

September 19, 2022

Presentation TCT 2022

Two-Stage Transcatheter Tricuspid Annuloplasty: Technology Description and First Human Case Demonstrating Concept Validation (Cardiac Implants)

Presenter: Mark Reisman

September 19, 2022

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

EMPOWER Trail Design & Patient Selection

Presentation TCT 2022

EMPOWER Trial Design & Patient Selection

Presenter: Samir Kapadia

September 19, 2022

Presentation TCT 2022

DurAVR THV First-in-Human Study - 30-day Results

Presenter: Christopher Meduri

September 18, 2022

Presentation TCT 2022

Leaflet Design's Impact on Physiology

Presenter: Joao Cavalcante

September 18, 2022

Presentation TCT 2022

Valve Function Insights from Bench Testing

Presenter: Janarthanan Sathananthan

September 18, 2022

Advertisement

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

Aortic Dissection Risk Rises With Thoracic Aneurysm Size: Large Network Study

No Benefit of LAA Ligation During HeartMate 3 Implantation: MOMENTUM 3

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

TCTMD’s Top 10 Most Popular Stories for September 2022

Another DOAC Fails in the Setting of Mechanical Heart Valves

Pascal TEER Device Performs Well in Patients With Complex Anatomy

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4

Valve Fracture for ViV TAVI Linked With Higher Mortality

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning

Newer FlexNav Delivery System Improves Placement of Portico TAVI Valve

TCT 360: The Importance of Leaflet Design in Initiation and Growth of Leaflet Thrombosis in Transcatheter Aortic Valves

Two-Stage Transcatheter Tricuspid Annuloplasty: Technology Description and First Human Case Demonstrating Concept Validation (Cardiac Implants)

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

EMPOWER Trial Design & Patient Selection

DurAVR THV First-in-Human Study - 30-day Results

Leaflet Design's Impact on Physiology

Valve Function Insights from Bench Testing

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content